MAYO CLINIC HEALTH SYSTEM - WASECA
1. Target Overview & Investment Thesis
MAYO CLINIC HEALTH SYSTEM - WASECA is a 15-bed suburban community hospital in WASECA, MN with $28.0M in net patient revenue and a 8.3% operating margin. The hospital serves a payer mix of 44.8% Medicare, 8.6% Medicaid, and 46.7% commercial.
Thesis: Turnaround. Our ML models identify $2.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 8.3% to 15.7% (+736bps).
| Net Revenue HCRIS | $28.0M |
| Current EBITDA COMPUTED | $2.3M |
| Operating Margin COMPUTED | 8.3% |
| Occupancy HCRIS | 63.2% |
| Revenue / Bed COMPUTED | $1.9M |
| Net-to-Gross HCRIS | 59.3% |
| Distress Probability ML | 48.9% |
2. Market Context & Competitive Position
MN has 141 Medicare-certified hospitals with a median operating margin of -3.6%. The target's margin of 8.3% places it above the state median. Among 86 size-comparable peers (8-30 beds), the median margin is -3.1%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (8-30), prioritizing same-state peers. 86 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| MAYO CLINIC HEALTH SYSTEM - WA (Target) | MN | 15 | $28.0M | 8.3% |
| CUYUNA REGIONAL MEDICAL CENTER | MN | 25 | $180.8M | -4.0% |
| MAYO CLINIC HEALTH SYSTEM - RE | MN | 27 | $149.3M | 1.8% |
| NEW ULM MEDICAL CENTER | MN | 24 | $128.6M | 4.2% |
| LAKEWOOD HEALTH SYSTEM | MN | 25 | $124.7M | 0.2% |
| AVERA MARSHALL REGIONAL MEDICA | MN | 25 | $115.2M | -17.0% |
| WELIA HEALTH | MN | 25 | $106.7M | 1.1% |
| CCH-MONTICELLO | MN | 25 | $97.7M | 9.2% |
| RIVERWOOD HEALTHCARE CENTER | MN | 25 | $85.5M | -2.9% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.1M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $587K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $559K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $554K | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $340K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $18K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $2.3M |
| + RCM Uplift | +$2.1M |
| Pro Forma EBITDA | $4.4M |
| Current Margin | 8.3% |
| Pro Forma Margin | 15.7% |
| WC Released (1x) | $1.1M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $3.6M | $35.9M | 10.05x | 58.6% |
| Base (11x exit) | 10.0x | 11.0x | $3.6M | $40.7M | 11.38x | 62.6% |
| Bull Case | 9.0x | 11.0x | $3.2M | $48.6M | 15.12x | 72.1% |
| Bull (12x exit) | 9.0x | 12.0x | $3.2M | $54.0M | 16.79x | 75.8% |
| Bear Case | 11.0x | 10.0x | $3.9M | $24.5M | 6.22x | 44.1% |
| Bear (11x exit) | 11.0x | 11.0x | $3.9M | $28.2M | 7.17x | 48.3% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Standard execution risk | RCM improvement requires management buy-in and 12-18 month implementation timeline |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 86 hospitals with 8-30 beds
- Same-state prioritization (n=90)
- Comp margins: P25=-12.9% / P50=-3.1% / P75=2.8%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.